#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic myelomonocytic leukaemia Stiff person syndrome Congenital disorder of glycosylation Stargardt's disease Facioscapulohumeral muscular dystrophy Conjunctivitis allergic Fibrosarcoma Arterial tortuosity syndrome Acute graft versus host disease in intestine Hypereosinophilic syndrome Hydrocephalus Congenital nephrogenic diabetes insipidus Alpha-1 antitrypsin deficiency Aspergillus infection Peritoneal neoplasm More trials…

    Learn about Rare Diseases

    Langerhans’ cell histiocytosis – Basic Information Malignant fibrous histiocytoma – Treatment Methylmalonic acidaemia – Trials in Disease X-linked lymphoproliferative syndrome – Basic Information Rhabdoid tumour – Trials in Disease Paroxysmal nocturnal haemoglobinuria – Diagnostics Familial haemophagocytic lymphohistiocytosis Primary immunodeficiency syndrome – Diagnostics Urea cycle disorder – Life with Disease Congenital nephrogenic diabetes insipidus More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TTX-381 Imatinib Mesilate AZD0022 Magnesium Chloride Sacubitril Bms-986340 Ethinylestradiol Salbutamol Benserazide Hydrochloride Tocilizumab Rp1 ATIGOTATUG Rosuvastatin ADX-038 Onfekafusp Alfa Tradipitant ELTANEXOR Mbf-118 Mk-1200 Suxamethonium Chloride More therapies…

    Learn about Your Condition

    Obstructive airways disorder Embolic stroke Follicular lymphoma stage III Osteoporosis Patent ductus arteriosus Osteosarcoma recurrent B-cell lymphoma refractory Thrombocytopenia Neonatal respiratory failure Milk allergy Lipid metabolism disorder Polyneuropathy Testicular leiomyosarcoma Mitral valve incompetence Gingival bleeding More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Center for Mental Health “Prof. N. Shipkovenski” EOOD…

Center for Mental Health “Prof. N. Shipkovenski” EOOD

Ulitsa Ekzarh Yosif 59, Sofia, 1000, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • A study to assess the safety and effectiveness of GXV813 in hospitalized adults with schizophrenia

    Recruiting

    2 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • GXV813
    Bulgaria

  • Study on ITI-1284 for Treating Agitation in Alzheimer’s Patients

    Recruiting

    2 1
    Investigated Drugs:
    • Iti-1284
    Bulgaria Croatia Czechia Romania Slovakia Spain

  • Study on ITI-1284 for Treating Psychosis in Alzheimer’s Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Dementia of the Alzheimer’s type with delusions
    • Psychotic disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Iti-1284
    Bulgaria Croatia Czechia Italy Poland Romania +2

  • Study on Seltorexant for Adults and Elderly with Major Depressive Disorder and Insomnia Symptoms

    Recruiting

    3 1
    Investigated Drugs:
    • SELTOREXANT
    Bulgaria Czechia Italy Poland Portugal Romania +3

  • Long-Term Safety Study of ACP-204 for Adults with Alzheimer’s Disease Psychosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy Spain

  • Study on Lumateperone for Treating Manic Episodes in Bipolar I Disorder Patients

    Not recruiting

    3 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Lumateperone
    Bulgaria Croatia

  • Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Valbenazine Ditosylate
    Bulgaria Croatia Czechia Romania Slovakia Spain

  • Study on RL-007 for Improving Cognitive Impairment in Schizophrenia Patients

    Not recruiting

    2 1
    Investigated Diseases:
    • Cognitive disorder
    • Schizophrenia
    Investigated Drugs:
    • (2R,3S)-2-Amino-3-Hydroxy-3-Pyridin-4-Yl-1-Pyrrolidin-1-Ylpropan-1-One (2R,3R)-2,3-Dihydroxybutanedioic Acid
    Bulgaria Czechia Poland

  • Study of ACP-204 for Treating Psychosis in Adults with Alzheimer’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy Spain

  • Study on Aticaprant for Adults with Major Depressive Disorder and Anhedonia Not Responding to Antidepressants

    Not recruiting

    3 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Aticaprant
    Belgium Bulgaria Czechia Finland Hungary Poland +2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!